Alphabet's AI Power Play Is Hiding In Plain Sight - And Investors Are Missing It
Alphabet's AI integration, robust cash flow, and profitable Google Cloud make it a top investment choice. See more on GOOG ...
Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
2 Unstoppable Artificial Intelligence (AI) Stocks to Buy in April and 1 to Avoid
While two AI leaders with undeniable competitive moats are historically cheap, another Wall Street darling is staring down a ...
Alphabet Is A Massive Cash Flow Machine With An Under-Leveraged Balance Sheet: Analyst
WestPark Capital initiated coverage on Alphabet with a Buy rating and $210 price target. Despite missing Q4 estimates, ...
Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
Alphabet: Poised For Explosive Returns After Selloff
Alphabet's diverse, high-margin growth engines like AI, Cloud & YouTube drive strong revenue growth. Click here to read my ...
BioPharma Dive2d
Isomorphic raises $600M on big ambitions for AI drugmaking tech
The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...
Alphabet Inc. (GOOG): Among the Best US Stocks to Buy For Foreign Investors
We recently published a list of 10 Best US Stocks To Buy For Foreign Investors. In this article, we are going to take a look ...